Home LiteratureArticle Details
PMID: 7173493 Published · ppublish English Journal Article

Detection of potentially reversible diabetic albuminuria. A three-drop agglutination test for urinary albumin at low concentration.

Diabetes ·Vol. 31 ·No. 11 ·1982-11-00 ·Pages 973-5

Viberti GC, Vergani D

Abstract

Subclinical elevation of urinary albumin excretion early in the course of insulin-dependent diabetes has been shown to predict later clinical proteinuria. An agglutination test (Three-drop Albutest) to detect these lesser degrees of albuminuria has been developed. Rabbit anti-human albumin antiserum is immobilized on latex beads. In the presence of human albumin and additional antiserum in solution, a visible precipitate appears. Concentration of solid and liquid phase antiserum have been adjusted to detect urinary albumin concentrations ranging between 2.5 and 17 mg/dl, undetectable by a standard clinical method (Albustix, Ames Company, Miles Laboratories Ltd, Stoke Poges, Slough, Bucks, England). The test is specific for albumin, failing to cross-react with other plasma proteins present in urine or with bovine serum albumin. It is simple to perform and is read within 5 min. This test should find a place in the early detection of diabetics with subclinical albuminuria and in monitoring the success of attempts to reverse this risk factor for clinical diabetic nephropathy.

MeSH Terms
Albuminuria/diagnosis Diabetes Mellitus/urine Humans Latex Fixation Tests/methods
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Viberti G C
Vergani D
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
Published
1982-11-00
Pages
973-5
Language
English
Region
United States
NLM ID
0372763
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com